La catena delle opzioni mostra i dati chiave delle opzioni azionarie di InflaRx a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per InflaRx..

InflaRx (NASDAQ:IFRX) Azioni, Catena delle Opzioni

InflaRx

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its lead product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

InflaRx NV

JP Morgan analyst Domingos Falavina downgrades Bank Bradesco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBD#NYSE">BBD</a>) from Overweight to Neutral.

News

Downgrades

Analyst Ratings

JP Morgan Downgrades Bank Bradesco to Neutral

Wedbush analyst Daniel Ives maintains Palantir Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) with a Outperform and raises the price target from $57 to $75.

Price Target

PLTR

Wedbush Maintains Outperform on Palantir Technologies, Raises Price Target to $75

JP Morgan analyst Jeffrey Zekauskas reinstates Berry Global Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BERY#NYSE">BERY</a>) with a Overweight and announces $76 price target.

Initiation

BERY

JP Morgan Reinstates Overweight on Berry Global Gr, Announces $76 Price Target

On Friday, November 22, U.S. markets closed higher, with all major indexes recording weekly gains. Optimism was driven by robust U.S. business activity and expectations of interest rate cuts.
However, tech faced pressure as Alphabet fell amid antitrust scrutiny, and Nvidia slipped following a cautious forecast. Investors also weighed geopolitical tensions, including Ukraine-Russia conflicts, and anticipated key developments, such as Trump&#8217;s Treasury Secretary selection.
According to economic data, the S&amp;P Global U.S. Services PMI rose to 57 in November from 55, while Manufacturing PMI edged up to 48.8 from 48.5. However, U.S. consumer sentiment dropped to 71.8, down from a preliminary 73 reading.
Industrials, financials, and consumer discretionary stocks led S&amp;P 500 gains Friday, while utilities and communication services lagged.
The Dow Jones Industrial Average was up 0.97% and closed at 44,296.51, the S&amp;P 500 gained 0.35% to 5,969.30, and the Nasdaq Composite rose 0.16% to finish at 19,003.65.
Asia Markets Today
<ul>
<li>On Monday, Japan&#8217;s Nikkei 225 gained 1.08% and ended the session at 38,735.00, led by gains in the Chemical, Petroleum &amp; Plastic, Mining and Textile sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 gained 0.28% and ended the day at 8,417.60, led by gains in the A-REITs, Healthcare, and Consumer Discretionary sectors.</li>
<li>India&#8217;s Nifty 50 rose 1.32% to 24,221.90, and Nifty 500 gained 1.58%, closing at 22,576.60, led by gains in the Oil &amp; Gas, Capital Goods, and Public Sector Undertakings sectors.</li>
<li>China&#8217;s Shanghai Composite declined 0.10% to close at 3,263.76, and the Shenzhen CSI 300 fell 0.46%, finishing the day at 3,848.09.</li>
<li>Hong Kong&#8217;s Hang Seng fell 0.41% and closed the session at 19,150.99.</li>
</ul>
Eurozone at 06:00 AM ET
<ul>
<li>The European STOXX 50 index was up 0.35%.</li>
<li>Germany&#8217;s DAX rose 0.45%.</li>
<li>France&#8217;s CAC gained 0.12%.</li>
<li>U.K.&#8217;s FTSE 100 index traded higher by 0.12%</li>
</ul>
Commodities at 06:00 AM ET
<ul>
<li>Crude Oil WTI was trading lower by 0.42% at $70.94/bbl, and Brent was down 0.40% at $74.32/bbl.</li>
<li>Oil prices steadied after last week&#8217;s 6% gains, driven by geopolitical tensions involving Russia and Iran. Markets await the OPEC+ meeting and rising Chinese crude demand, while potential U.S. sanctions on Iran threaten supply disruptions.</li>
<li>Natural Gas rose 3.99% to $3.418.</li>
<li>Gold was trading lower by 1.21% at $2,703.90, Silver was down 1.56% to $31.282, and Copper gained 0.67% to $4.1612.</li>
</ul>
U.S. Futures at 06:00 AM ET
Dow futures gained 0.68%, S&amp;P 500 futures were up 0.51% and Nasdaq 100 futures rose 0.61%.
Forex at 06:00 AM ET
The U.S. dollar index fell 0.55% to 106.97, the USD/JPY was down 0.23% to 154.38, and the USD/AUD rose 0.39% to 1.5355.
Photo by Pavel Bobrovskiy via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

Markets

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia Mixed, Europe Markets Gain While Gold And Dollar Dip - Global Markets Today While US Slept

<ul>
<li>The transaction will be implemented pursuant to a previously announced prearranged chapter 11 plan supported and funded by 100 percent of CareMax's current secured lenders (the "Prearranged Plan"). The sale of the Core Centers' Assets is anticipated to be consummated simultaneously with CareMax's Prearranged Plan.</li>
<li>CareMax has obtained Court approval to maintain business-as-usual operations to ensure the Company's medical centers and physician affiliates continue providing uninterrupted, high-quality care and service to all patients.</li>
</ul>

Health Care

General

CMAX

ClareMedica Health Partners Has Entered Into A "Stalking Horse" Purchase Agreement With CareMax To Purchase CareMax's Core Centers' Assets Including A Vast Majority Of CareMax's Operating Clinics

Under the terms of the agreement BXCI will provide EQT $3.5 billion of cash consideration in exchange for a non-controlling common equity interest in the JV.&nbsp;
The investment implies a total JV valuation of approximately $8.8 billion, or 12x EBITDA. The JV provides EQT with a large-scale equity capital solution at an accretive cost of capital.&nbsp;
Additionally, EQT will retain the rights to growth projects associated with the assets contributed to the JV, including the planned Mountain Valley Pipeline ("MVP") expansion and the MVP Southgate project.
EQT plans to use proceeds from this transaction to pay down its term loan and revolving credit facility and redeem and tender for senior notes.&nbsp;
 &nbsp;

EQT Enters Definitive Agreement With Funds Managed By Blackstone Credit & Insurance To Form New $3.5B Midstream Joint Venture

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.gctsemi.com&amp;esheet=54157480&amp;newsitemid=20241125186361&amp;lan=en-US&amp;anchor=GCT+Semiconductor+Holding+Inc.&amp;index=1&amp;md5=b1d413e4a77dc13f33b9a00307a04cc3">GCT Semiconductor Holding Inc.</a> ("GCT" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GCTS#NYSE">GCTS</a>), a leading designer and supplier of advanced 5G and 4G semiconductor solutions, announced today the signing of a definitive agreement with a European tier one wireless infrastructure and terminal provider (the "Tier One Supplier") to collaborate on the development of Fixed Wireless Access ("FWA") technology using GCT's 5G solutions including modem chipset and RFIC.
The Company previously announced the signing of an <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.pressviewer.com%2Fprofiles%2Finvestor%2FNewsPrint.asp%3Fv%3D6%26b%3D2932%26ID%3D137001%26m%3Drl%26g%3D2763&amp;esheet=54157480&amp;newsitemid=20241125186361&amp;lan=en-US&amp;anchor=MOU+with+the+Tier+One+Supplier&amp;index=2&amp;md5=22076aa6120c7cd56d052f4fe151f7b7">MOU with the Tier One Supplier</a> in August 2024, a continuation of an existing key customer relationship now moving to 5G. GCT expects the launch of FWA devices related to this activity to commence in the second half of 2025.
"This collaboration is a major milestone and reinforces the momentum we are gaining in solidifying customer engagement and strengthening client relationships for growth as we prepare for our 5G chipset launch," said John Schlaefer, CEO of GCT. "We look forward to working together on this significant partner's 5G portfolio and high-performing FWA technology."
The growing 5G FWA technology is a cost-effective alternative to traditional wired broadband options and offers reliable connectivity in remote or underserved areas. Based on the Ericsson Mobility Report (June 2024)&#x2A;, the number of 5G FWA connections worldwide is projected to increase over 800% from the end of 2023 to the end of 2029, representing an increase from ~30 million connections to ~280 million connections. With its strong expertise in 5G chip development, GCT is fully prepared to take advantage of this growing market.

GCTS

GCT Semiconductor Teams Up with European Supplier to Drive 5G Fixed Wireless Access Innovation, Targets 2025 Device Launch

Nasdaq will file a delisting notice with the SEC. Oncternal has stated it will not appeal the decision.
&nbsp;

Biotech

ONCT

On November 22, Oncternal Therapeutics Announced That Nasdaq Plans To Delist Its Stock On December 3, Nasdaq Classified The Company As "Public Shell,"  Following Its Decision To Lay Off Employees And Explore Strategic Alternatives-Filing

Wedbush analyst Daniel Ives upgrades Elastic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) from Neutral to Outperform and announces $135 price target.

Upgrades

ESTC

Wedbush Upgrades Elastic to Outperform, Announces $135 Price Target

JP Morgan analyst Michael Rehaut downgrades Smith Douglas Homes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SDHC#NYSE">SDHC</a>) from Overweight to Neutral and lowers the price target from $41 to $36.

SDHC

JP Morgan Downgrades Smith Douglas Homes to Neutral, Lowers Price Target to $36

Elon Musk&#8217;s Tesla Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) is actively recruiting software engineers to enhance its teleoperation <a href="https://www.benzinga.com/topic/tesla-cybercab">capabilities for robotaxis</a> and <a href="https://www.benzinga.com/topic/tesla-optimus">the Optimus robot</a>.
What Happened: The initiative, spearheaded by Tesla AI's Teleoperation team, focuses on developing low-latency, reliable data streaming solutions for real-world applications.
According to&nbsp;Tesla&#8217;s career page, the company aims to provide remote access to its autonomous vehicles and humanoid robots.
The team is tasked with integrating hardware, firmware, and backend systems to create a sophisticated teleoperation system.
Remote operators will use advanced virtual reality rigs to perform complex tasks, bridging the gap between the physical and digital worlds so remote teleoperators can provide accurate guidance and intervene when necessary.
Engineers will collaborate with hardware teams to define requirements, make design choices, and implement software for the teleoperation system.
Applicants should have experience with C++, Python, 3D graphics, and game engines like Unreal. Familiarity with Windows and Linux environments, networking, and custom shaders is also required.
Tesla's teleoperation role offers a salary range of $120,000 to $318,000, including cash, stock awards, and benefits.
See Also:&nbsp;<a href="https://www.benzinga.com/24/11/42131163/tesla-ceo-elon-musk-attempts-to-temper-down-expectations-of-30k-optimus-or-cybercab-soon?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla CEO Elon Musk Tries To Lower Expectations Of $30K Optimus Or Cybercab</a>
Why It Matters: The recruitment drive comes at a time when&nbsp;<a href="https://www.benzinga.com/markets/equities/24/11/42029753/teslas-fsd-hits-a-milestone-with-95-mile-unassisted-drive-from-manhattan-to-connecticut-analyst-pierre-ferragu-says-robotaxi-never-felt-that-close-ever-before">Tesla&#8217;s Full Self-Driving (FSD) technology</a>&nbsp;has achieved a significant milestone. Analyst&nbsp;Pierre Ferragu&nbsp;recently highlighted a 95-mile unassisted drive from Manhattan to Connecticut, showcasing Tesla&#8217;s progress in autonomous driving.
Furthermore,&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41593922/cathie-woods-ark-invest-sees-tesla-unlocking-11-trillion-revenue-potential-with-rob">ARK Investment Management</a>&nbsp;has projected that Tesla&#8217;s robotaxi fleet could unlock a staggering $11 trillion revenue potential, surpassing current ride-hailing services like&nbsp;Uber Technologies Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) and&nbsp;LYFT Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>). This potential revenue stream underscores the importance of Tesla&#8217;s teleoperation capabilities.
Additionally, Tesla&#8217;s&nbsp;<a href="https://www.benzinga.com/news/24/10/41376564/tesla-showcases-optimus-autonomous-navigation-charging-abilities-after-admitting-they-were-human-ass">Optimus robot</a>&nbsp;has demonstrated autonomous navigation and charging abilities, further emphasizing the company&#8217;s advancements in robotics. The robot can now navigate Tesla&#8217;s factory autonomously, avoiding obstacles and interacting with humans.
Price Action: Tesla stock closed 3.80% higher on Friday at $352.56. Year-to-date, it is up 41.92%, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/space/24/11/42082169/elon-musk-predicts-tesla-cybertrucks-optimus-robots-will-be-aboard-spacex-starships-to-mars-in-2-years?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Predicts Tesla Cybertrucks, Optimus Robots Will Be Aboard SpaceX Starships To Mars In 2 Years</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Tesla

Tech

LYFT

TSLA

UBER

Elon Musk's Tesla Hunts Top Talent To Develop Software For Robotaxi, Optimus Robot Teleoperation

JP Morgan analyst Bryan Smilek initiates coverage on Coursera (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) with a Neutral rating and announces Price Target of $8.

COUR

JP Morgan Initiates Coverage On Coursera with Neutral Rating, Announces Price Target of $8

DA Davidson analyst Linda Bolton Weiser upgrades Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) from Neutral to Buy and raises the price target from $160 to $209.

DA Davidson Upgrades Procter & Gamble to Buy, Raises Price Target to $209

Canaccord Genuity analyst Edward Nash initiates coverage on Apogee Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APGE#NASDAQ">APGE</a>) with a Buy rating and announces Price Target of $89.

APGE

Canaccord Genuity Initiates Coverage On Apogee Therapeutics with Buy Rating, Announces Price Target of $89

Wedbush analyst Daniel Ives upgrades Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) from Neutral to Outperform and announces $190 price target.

SNOW

Wedbush Upgrades Snowflake to Outperform, Announces $190 Price Target

Old National Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONB#NASDAQ">ONB</a>) ("Old National") and Bremer Financial Corporation ("BFC" or "Bremer") jointly announced today that they entered into a definitive merger agreement. Founded in 1943, BFC is the bank holding company for Bremer Bank.
As of September 30, 2024, Bremer had $16.2 billion in total assets, $11.5 billion in total loans, and $13.2 billion in deposits. After the partnership is completed, Old National will become the third-largest bank in the Twin Cities. In addition, the partnership expands Old National's reach into several other vibrant markets throughout Minnesota, North Dakota and Wisconsin. Once combined, the new organization would have over $70 billion in assets (based on September 30, 2024 asset figures), a significantly larger footprint, and offer additional banking capabilities and enhanced resources to serve customers.
"This partnership represents an outstanding fit between two highly compatible, relationship- and community-focused banks," said Old National Chairman and CEO Jim Ryan. "When you look at what has made Bremer Bank a leading institution since 1943, what you quickly find are the same strategic priorities and cultural principles that have guided Old National's success for 190 years: a strong deposit franchise, a diversified loan portfolio accentuated by exceptional credit quality, and a passion for investing in and strengthening communities. I am incredibly confident that, through this partnership, Bremer and Old National will be even better together."
"For more than 80 years, we've been honored to carry out the legacy of our founder, Otto Bremer," said Jeanne Crain, President and CEO of Bremer. "When our majority shareholder, the Otto Bremer Trust, reaffirmed its interest in selling Bremer Bank, we appreciated the opportunity to identify a partner through a collaborative process to ensure the best possible outcome for our customers, employees, and our communities. With Old National, we have confidence we found a great fit."
The Otto Bremer Trust The Otto Bremer Trust (the "Trust") is a private charitable trust based in St. Paul, Minnesota. It currently holds a majority ownership stake in Bremer. Established in 1944, the Trust works to combine finance and philanthropy in service of the community. Since its inception, the Trust has made more than $1.1 billion in grants and program-related investments to more than 4,200 organizations.
Upon closing of this transaction, the Trust will have an approximate 11% ownership stake in Old National and a Trustee of the Otto Bremer Trust will join the Old National Board of Directors.
The Otto Bremer Trust commented: "All of us at the Otto Bremer Trust are excited that the Bremer Bank legacy of investing in people, places and opportunities continues with one of the most community-minded banks in the nation. This partnership expands the scope of what can be accomplished for and within our communities – civically, socially and economically."
The partnership transaction includes 70 total banking centers in Minnesota, North Dakota and Wisconsin
48 branches in Minnesota, including:
<ul>
<li>18 locations in the Twin Cities region</li>
<li>5 locations in the Rochester region</li>
<li>7 locations in the Alexandria region</li>
<li>4 locations in the St. Cloud region</li>
</ul>
14 branches in North Dakota, including:
<ul>
<li>6 locations in the Grand Forks region</li>
<li>7 locations in the Fargo region</li>
</ul>
8 branches in Wisconsin, including:
<ul>
<li>1 location in Appleton</li>
<li>1 location in Eau Claire</li>
</ul>
Under the terms of the definitive merger agreement, each outstanding share of Bremer common stock will be converted into the right to receive 4.182 shares of Old National common stock plus $26.22 in cash, valuing the transaction at approximately $1,401 million, or $116.76 per share, based on Old National's closing stock price on November 22, 2024. The definitive merger agreement has been unanimously approved by the Board of Directors of Bremer and Old National. The transaction is subject to customary closing conditions and regulatory approvals, including the approval of Bremer shareholders. The transaction is anticipated to close in the middle of 2025.
&nbsp;

Old National Acquires Bremer Bank in $1.4B Deal, Expanding Midwest Footprint

JMP Securities analyst Aaron Kimson downgrades Expensify (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXFY#NASDAQ">EXFY</a>) from Market Outperform to Market Perform.

EXFY

JMP Securities Downgrades Expensify to Market Perform

Meents most recently served as President of Intermodal &amp; Transportation Solutions, Chief Marketing Officer, and in various other operational, account management, pricing, sales and marketing roles since joining the Company in 2009.
Brian Alexander, previously the Company's Chief Operating Officer, will assume the role of Chief Marketing Officer.

Management

HUBG

Hub Group Board Appoints Brian Meents As Executive Vice President And COO - Filing

Old National Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONB#NASDAQ">ONB</a>) ("Old National") today announced the pricing of an underwritten public offering of 19,047,619 shares of its common stock, no par value (the "Common Stock"), at a public offering price of $21.00 per share (before underwriting discounts and commissions), for an aggregate offering amount of $400 million. The approximate net proceeds of the offering will be $384 million (before offering expenses, assuming the underwriters do not exercise their option to purchase additional shares and assuming full physical settlement of the forward sale agreement at the initial forward price) in connection with the forward sale agreement described below.

Offerings

Old National Bancorp To Raise $400M Via Secondary Stock Offering Of 19M Shares At $21/Share

In a remarkable turn of events, MicroStrategy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) saw its shares jump by 5.93% in pre-market trading on Monday, as per <a href="https://pro.benzinga.com">Benzinga Pro</a>. This surge comes on the heels of co-founder Michael Saylor&#8216;s announcement that the company is generating $500 million daily as Bitcoin edges closer to the $100,000 mark.
What Happened: At the time of reporting, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) was valued at $98,273.58. The cryptocurrency&#8217;s rise has significantly impacted MicroStrategy&#8217;s performance, as the company has heavily invested in Bitcoin.
On the same day,&nbsp;Canaccord Genuity&nbsp;reaffirmed its Buy rating for MicroStrategy&#8217;s stock, elevating its price target from $300.00 to $510.00. The firm commended MicroStrategy&#8217;s novel strategy in assessing&nbsp;value creation through a new&nbsp;key performance indicator centered&nbsp;on Bitcoin accretion per share&nbsp;and Bitcoin yield.
See Also: <a href="https://www.benzinga.com/general/social-media/24/11/42154487/robert-kiyosaki-trump-will-make-america-richer-again-by-being-the-first-bitcoin-president?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Robert Kiyosaki: &#8216;Trump Will Make America Richer Again By Being The First Bitcoin President&#8217;</a>
Why It Matters: Saylor recently revealed that <a href="https://www.benzinga.com/24/11/42151809/michael-saylor-reveals-microstrategy-is-making-500m-a-day-with-bitcoin-may-very-well-be-the-most-profitable-company-in-the-us-growing-the-fastest-right-now">MicroStrategy is minting $500 million a day</a> as Bitcoin approaches $100,000 for the first time. Saylor highlighted the company&#8217;s massive gains, noting that their Bitcoin holdings appreciated by $5.4 billion over two weeks. This underscores the significant impact of Bitcoin&#8217;s value on MicroStrategy&#8217;s financial health.
However, not everyone is convinced of MicroStrategy&#8217;s valuation.&nbsp;<a href="https://www.benzinga.com/24/11/42156261/are-microstrategys-shares-worth-only-105-investment-adviser-gary-black-weighs-in">Investment adviser Gary Black</a>&nbsp;questioned the company&#8217;s stock price, suggesting it might be overpriced. Black pointed out that while MicroStrategy&#8217;s Bitcoin holdings were valued at $31.2 billion, the company&#8217;s market value was $106 billion, raising concerns about its equity value.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42146459/bitcoin-on-brink-of-breaking-100000-dogecoin-up-ethereum-down-crypto-community-holds-its-breath-as-btc-guns-for-milestone?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bitcoin &#8216;On Brink Of Breaking $100,000,&#8217; Dogecoin Up, Ethereum Down: Crypto Community Holds Its Breath As BTC Guns For Milestone</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Image via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

Pre-Market Outlook

$BTC

MSTR

MicroStrategy Shares Rise In Monday Pre-Market As Michael Saylor Reveals MSTR Generating $500M Daily Amid Bitcoin's Surge

InflaRx reports Q3 results

As of September 30, 2024, InflaRx's (IFRX) total available funds amounted to EUR 62.0 million, composed of EUR 26.2 million in cash and cash equiva...

InflaRx expects cash to fund operations into 2026

LifeSci Capital analyst Sam Slutsky maintained a Hold rating on InflaRx (IFRX – Research Report) today. The company's shares closed last Friday at ...

LifeSci Capital Keeps Their Hold Rating on InflaRx (IFRX)

Inflarx N.V. ( ($IFRX) ) has released its Q3 earnings. Here is a breakdown of the information Inflarx N.V. presented to its investors. InflaRx N.V....

InflaRx Reports Q3 2024 Financial Results and Progress

InflaRx (IFRX) announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion re...

InflaRx receives positive CHMP opinion for GOHIBIC for SARS-CoV-2-induced ARDS

InflaRx (IFRX) has released an update. InflaRx has received a positive opinion from the European Medicines Agency's CHMP for GOHIBIC, a treatment t...

InflaRx Gets EMA Nod for COVID-19 Treatment

InflaRx receives positive CHMP opinion for SARS-CoV-2-induced acute respiratory distress treatment

In a report released today, Edward White from H.C. Wainwright reiterated a Buy rating on InflaRx (IFRX – Research Report), with a price target of $...

InflaRx Buy Rating: Promising Developments and Market Opportunities for Gohibic

In a report released today, Sam Slutsky from LifeSci Capital maintained a Hold rating on InflaRx (IFRX – Research Report). The company's shares ope...

LifeSci Capital Reaffirms Their Hold Rating on InflaRx (IFRX)

Leerink Partners analyst Joseph Schwartz has maintained their bullish stance on IFRX stock, giving a Buy rating on November 15. Joseph Schwartz's r...

Positive Outlook for InflaRx: Regulatory Milestones and Promising Pipeline Drive Buy Rating

IFRX

Press Releases

InflaRx's GOHIBIC (Vilobelimab) Selected for First BARDA-Sponsored Clinical Trial to Evaluate Novel Host-Directed Therapeutics for Acute Respiratory Distress Syndrome (ARDS)

InflaRx to Present New Preclinical Data on INF904 at the 19th European Meeting on Complement in Human Diseases

InflaRx to Report Second Quarter 2024 Results on August 8, 2024

Earnings

InflaRx Reports Second Quarter 2024 Financial Results and Provides Business Update

InflaRx Announces Participation in September Investor Events

InflaRx Presents New Preclinical Findings for INF904 at the 19th European Meeting on Complement in Human Diseases

InflaRx Presents Post Hoc Analysis of SHINE Trial of Vilobelimab in Hidradenitis Suppurativa at the 2024 European Academy of Dermatology and Venereology Congress

Comments

InflaRx

InflaRx (IFRX) Opzioni

InflaRx (NASDAQ:IFRX) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO